Announcements Trials

Browse Landscape Eligibility

Clinical Trials

2 trials

Recent Start date Enrollment

Phase EARLY_PHASE1 × Polycystic Ovary Syndrome × ganirelix × Clear all

Phase

Phase EARLY_PHASE1 2 Phase 4 1

Status

Sponsor Class

Study Type

Interventional 2

Sponsor

Conditions

Polycystic Ovary Syndrome 2

Interventions

Metformin 6 Spironolactone 4 ganirelix 2 Progesterone 2 Pioglitazone 2 Ovidrel 2 Hydrocortisone 2 Cosyntropin 2 Thyrotropin 1 Testosterone 1 Methyltestosterone 1 Luteinizing Hormone 1 Leuprolide 1 Inositol 1 Estradiol 1 Dexamethasone 1 Contraception 1 Body Mass Index 1 Blood Urea Nitrogen 1 Adrenocorticotropic Hormone 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT05751252 2025-04-27

SOPKGANI

University Hospital, Lille

Phase EARLY_PHASE1 Completed

Polycystic Ovary Syndrome

NCT00757185 2016-07-04

Compromised Microcirculation in Women With Polycystic Ovary Syndrome

Yale University

Phase EARLY_PHASE1 Completed

Polycystic Ovary Syndrome

Data powered by HemOnc (CC BY 4.0) Colophon ⚡